tradingkey.logo
搜索

Charles River Laboratories International Inc

CRL
添加自选
202.110USD
+15.510+8.31%
收盘 06/24, 16:00美东报价延迟15分钟
9.73B总市值
亏损市盈率 TTM

Charles River Laboratories International Inc

202.110
+15.510+8.31%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+8.31%

5天

+10.84%

1月

+26.08%

6月

-0.52%

今年开始到现在

+1.32%

1年

+36.19%

关键数据
190.100今开
202.780最高
936.73K成交量
亏损市盈率 TTM
16.21市盈率动
--股息TTM
1.94%换手率
186.600昨收
190.100最低
99.69M成交额
945.42市盈率静
3.31市净率
0.00%股息率 TTM
-2.39%ROA
228.88052周最高
1.13量比
10.30M净利润
48.17M总股本
-3.7180每股收益TTM
1.46Beta
-6.02%ROE
132.58352周最低
6.80%振幅
30.90%毛利率
9.73B总市值
7.39回报/风险
2.58%风险率

操作建议

Charles River Laboratories International Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名12/388位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价216.82。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Charles River Laboratories International Inc评分

相关信息

行业排名
12 / 388
全市场排名
51 / 4571
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

42°C

过冷
过热
看好

Charles River Laboratories International Inc亮点

亮点风险
Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
业绩转亏
公司业绩转亏,最新年度亏损美元
估值合理
公司最新PE估值-54.36,处于3年历史合理位
机构减仓
最新机构持股56.13M股,环比减少12.43%
约翰·罗杰斯持仓
明星投资者约翰·罗杰斯持仓,最新持仓市值1.51M

分析师目标

根据 19 位分析师
买入
评级
216.820
目标均价
+17.20%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Charles River Laboratories International Inc简介

Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
公司代码CRL
公司Charles River Laboratories International Inc
CEOFoster (James C)
网址https://www.criver.com/

常见问题

Charles River Laboratories International Inc(CRL)的当前股价是多少?

Charles River Laboratories International Inc(CRL)的当前股价是 202.11。

Charles River Laboratories International Inc的股票代码是什么?

Charles River Laboratories International Inc的股票代码是CRL。

Charles River Laboratories International Inc股票的52周最高点是多少?

Charles River Laboratories International Inc股票的52周最高点是228.88。

Charles River Laboratories International Inc股票的52周最低点是多少?

Charles River Laboratories International Inc股票的52周最低点是132.58。

Charles River Laboratories International Inc的市值是多少?

Charles River Laboratories International Inc的市值是9.74B。

现在Charles River Laboratories International Inc(CRL)的股票是买入、持有还是卖出?

根据分析师评级,Charles River Laboratories International Inc(CRL)的总体评级为买入,目标价格为216.82。

Charles River Laboratories International Inc(CRL)股票的每股收益(EPS TTM)是多少

Charles River Laboratories International Inc(CRL)股票的每股收益(EPS TTM)是-2.91。
KeyAI